Ledger.Open graph →
SEC Form D · Amendment · filed October 24, 2023

Claris Biotherapeutics, Inc

Offering
$44.5M
Sold
$44.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
JERSEY CITY, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Kenneth C. Harrison · Jersey City, NJDirectorMeredith C. Fisher · Jersey City, NJDirectorReza C. Dana · Jersey City, NJDirectorClarke Atwell · Jersey City, NJExec · DirectorMarc C. De Garidel · Jersey City, NJDirectorLewis Teal · Vancouver, British Columbia, CanadaDirectorClarke Atwell · Jersey City, NJExec · DirectorTerese Gieselman · Vancouver, British Columbia, CanadaDirectorShehzad Khan · NEW YORK, NYDirectorVanessa Barrett · Grand Cayman, Cayman IslandsDirectorMark Floyd · Plano, TXDirectorAndrew T. Basham · Richmond, VADirectorS. T. Williams · Richmond, VADirectorSunriver Management LLC · Greenwich, CTDirectorLeslie G. Cohen · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗